An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.
Trial drug can significantly block early stages of COVID-19 in engineered human tissues
- ScienceDaily
- 2. 4 2020 (20:45)
An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.